Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis
Selective cyclo-oxygenase-2 inhibition causes autologous endometrial grafts to regress by reducing vascular endothelial growth factor-mediated angiogenesis and increasing caspase-3-dependent apoptosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (73)
- [Angiogenesis and endometriose] via crossref
- [Angiogenesis and endometriose] via openalex
- Angiogenesis: a new theory for endometriosis via openalex
- Angiogenesis: a new theory for endometriosis via crossref
- Angiogenic factors in endometriosis via crossref
- Angiogenic factors in endometriosis via openalex
- Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions via crossref
- Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions via openalex
- Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats via crossref
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via crossref
- Expression of angiogenic factors in extrapelvic endometriosis via openalex
- Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density via openalex
- Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata via crossref
- Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata via openalex
- Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients via crossref
- In vivo analysis of angiogenesis in endometriosis-like lesions by intravital fluorescence microscopy via crossref
- In vivo analysis of angiogenesis in endometriosis-like lesions by intravital fluorescence microscopy via openalex
- Medical management of endometriosis: novel targets and approaches towards the development of future treatment regimes via openalex
- Medical management of endometriosis: novel targets and approaches towards the development of future treatment regimes via crossref
- Medical treatment of endometriosis via openalex
- Medical treatment of endometriosis via crossref
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis via openalex
- Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib via crossref
- Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib via openalex
- Studies on the surgical induction of endometriosis in the rat via crossref
- Survivin gene expression in endometriosis via crossref
- Survivin gene expression in endometriosis via openalex
- The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis via crossref
- Vascular development in endometriosis via openalex
- Vascular development in endometriosis via crossref
- Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis via crossref
- W1968316164 via openalex
- W1969169755 via openalex
- W1974922031 via openalex
- W155792476 via openalex
- W1985959551 via openalex
- doi:10.1016/0092-8674(95)90127-2 via crossref
- doi:10.1038/nm0901-1041 via crossref
- doi:10.1016/0167-5699(93)90179-o via crossref
- W2039274017 via openalex
- W2040095832 via openalex
- doi:10.1016/0026-2862(74)90043-0 via crossref
- W2043707891 via openalex
- W2052582923 via openalex
- doi:10.1677/joe.0.1720535 via crossref
- W2068885726 via openalex
- W2097620342 via openalex
- W2097716284 via openalex
- doi:10.1016/0018-506x(77)90047-2 via crossref
- W2105803518 via openalex
- doi:10.1159/000048893 via crossref
- doi:10.1161/01.cir.0000143234.51796.a9 via crossref
- W2115475125 via openalex
- W2141215190 via openalex
- W2146060718 via openalex
- doi:10.1172/jci9621 via crossref
- W2148122132 via openalex
- doi:10.1007/s00432-004-0620-5 via crossref
- W2158686638 via openalex
- W2159973565 via openalex
- W2165663767 via openalex
- doi:10.1073/pnas.91.6.2046 via crossref
- W2346020725 via openalex
- doi:10.1074/jbc.271.52.33157 via crossref
- W6606350513 via openalex
- W6629591972 via openalex
- W6655318352 via openalex
- W6659841928 via openalex
- W6674553020 via openalex
- W6681627999 via openalex
- W1496912415 via openalex
- W6681761019 via openalex
Cited by (50)
- Endometriosis and ovulatory menstruation: beyond the Sampson principle 2025
- Research Progress of Caspase in Endometriosis 2024
- Effects of selective inhibition of prostaglandin E2 receptors EP2 and EP4 on the miRNA profile in endometriosis 2022
- PPARγ Agonists: Emergent Therapy in Endometriosis 2021
- Endometriosis, infertility and MicroRNA's: A review 2021
- Use of selective PGE2 receptor antagonists on human endometriotic stromal cells and peritoneal macrophages 2020
- Dose-Dependent Decreased Fertility in Response to the Burden of Endometriosis in a Murine Model 2019
- Cyclooxygenase-2 in Endometriosis 2019
- Suppressive Effects of Ursolic Acid on Human Endometriotic Stromal Cells Survival 2019
- Comparing The Effects of Glycyrrhiza glabra Root Extract, A Cyclooxygenase-2 Inhibitor (Celecoxib) and A Gonadotropin-Releasing Hormone Analog (Diphereline) in A Rat Model of Endometriosis 2019
- Eutopic stromal cells of endometriosis promote neuroangiogenesis via exosome pathway† 2018
- 6-Shogaol reduces progression of experimental endometriosis in vivo and in vitro via regulation of VGEF and inhibition of COX-2 and PGE2-mediated inflammatory responses 2018
- Basic mechanisms of vascularization in endometriosis and their clinical implications 2018
- Concentration effect of prostaglandin E2 on the growth factor expression and cell proliferation in bovine endometrial explants and their kinetic characteristics 2017
- Targeting hypoxia-mediated YAP1 nuclear translocation ameliorates pathogenesis of endometriosis without compromising maternal fertility 2017
- Summary of Future Developments 2017
- Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions 2017
- Hypoxia-inducible factor-1alpha: A promising therapeutic target in endometriosis 2016
- Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment 2016
- Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions 2016
- -1195 A/G promoter variants of the cyclooxygenase-2 gene increases the risk of pain occurrence in endometriotic women 2016
- COX-2 gene promoter DNA methylation status in eutopic and ectopic endometrium of Egyptian women with endometriosis 2015
- Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis 2015
- A rare case of endometrioma in a bitch 2015
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells 2015
- MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? 2015
- CD26/DPPIV down-regulation in endometrial stromal cell migration in endometriosis 2014
- Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions 2014
- Roles of Prostaglandin E2 in Endometriosis 2014
- Regression of experimentally induced endometriosis with a new selective cyclooxygenase-2 enzyme inhibitor 2013
- Suppression of annexin A2 by prostaglandin E₂ impairs phagocytic ability of peritoneal macrophages in women with endometriosis 2013
- Identification of multiple and distinct defects in prostaglandin biosynthetic pathways in eutopic and ectopic endometrium of women with endometriosis 2013
- Pathogenesis of endometriosis: the role of initial infection and subsequent sterile inflammation (Review) 2013
- A Critical Review of Endometriosis Pathology 2013
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms 2012
- New perspectives for the treatment of endometriosis 2012
- Non-hormonal targets for the medical treatment of endometriosis 2012
- Anti-angiogenic treatment strategies for the therapy of endometriosis 2012
- Peritoneal endometriosis is an inflammatory disease 2012
- Regulación del crecimiento del tejido endometrial en respuesta a nuevas alternativas terapéuticas propuestas para tratar la endometriosis 2012
- Anastrozole and celecoxib for endometriosis treatment, good to keep them apart? 2012
- Hypoxia-inhibited dual-specificity phosphatase-2 expression in endometriotic cells regulates cyclooxygenase-2 expression 2011
- The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies 2011
- Hypoxia induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human endometrial cells 2011
- In vitro and in vivo evaluation of the anti-angiogenic actions of 4-hydroxybenzyl alcohol 2011
- Prostaglandin E2: the master of endometriosis? 2010
- Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model 2010
- Suppression of migratory/invasive ability and induction of apoptosis in adenomyosis-derived mesenchymal stem cells by cyclooxygenase-2 inhibitors 2010
- The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial tissues and angiogenesis in a mouse implantation model 2010
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases 2010
Source provenance
- crossref
- last seen: 2026-08-29T06:28:37.612972+00:00
- europepmc
- last seen: 2026-10-10T06:11:15.153948+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:04:05.892929+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00